These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3686837)

  • 1. [Use of nuclear magnetic resonance in a study of erythrocyte metabolism].
    Fábryová V; Goljer J; Goljer I; Zalibera L
    Vnitr Lek; 1987 Oct; 33(10):865-71. PubMed ID: 3686837
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in erythrocyte metabolism during treatment of experimental salmonellosis poisoning].
    Tselik NI; Zakharova NB
    Patol Fiziol Eksp Ter; 1983; (6):12-4. PubMed ID: 6664688
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of the 2,3-diphosphoglycerate shunt in regulating energy metabolism in human erythrocytes].
    Kholodenko BN; Stepanchikova AV; Erlikh LI; Ataullakhanov FI; Zhabotinskiĭ AM
    Izv Akad Nauk SSSR Biol; 1985; (2):196-205. PubMed ID: 3157714
    [No Abstract]   [Full Text] [Related]  

  • 4. [Age composition of the erythrocyte population, ATP and 2,3-diphosphoglycerate composition in erythrocytes in different forms of hemolytic anemia].
    Luganova IS; Blinov MN; Abdulkadyrova AS
    Vopr Med Khim; 1978; 24(4):499-505. PubMed ID: 685194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorus-31 nuclear magnetic resonance studies of human red blood cells.
    Tehrani AY; Lam YF; Lin AK; Dosch SF; Ho C
    Blood Cells; 1982; 8(2):245-61. PubMed ID: 7159749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2,3 diphosphoglycerate-haemoglobin binding in uraemic patients treated with erythropoietin. A 31P-nuclear magnetic resonance study.
    Monti JP; Brunet P; Baz M; Klinkmann H; Berland Y; Merzouk T; Elsen R; Crevat A
    Nephrol Dial Transplant; 1993; 8(3):223-6. PubMed ID: 8385288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erythrocyte metabolism in patients with acute leukemia and a deficiency of the enzyme pyruvate kinase].
    Labar B; Stavljenić A; Jusufhodzić L
    Lijec Vjesn; 1984; 106(11-12):447-51. PubMed ID: 6596474
    [No Abstract]   [Full Text] [Related]  

  • 8. [31P-NMR study of kinetics of 2,3-diphosphoglycerate degradation in human erythrocytes during their depletion].
    Ataullakhanov FI; Vitvitskiĭ VM; Dubinskaia EI; Dubinskiĭ VZ
    Biokhimiia; 1985 Aug; 50(8):1319-22. PubMed ID: 4074797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic renal insufficiency undergoing conservative therapy: hemorheological pattern and erythrocytic metabolic parameters].
    Caimi G; Vaccaro F; Romano A; Serra A; Picone FP; D'Asaro S; Catania A; Sarno A
    Ric Clin Lab; 1989; 19 Suppl 1():153-7. PubMed ID: 2629077
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of fructose-1, 6-diphosphate effects on erythrocytic 2, 3 diphosphoglycerate and ATP in surgical orthopedic patients.
    Urso L; Brillante C; Orlandi M; Rotundo M; Ballati S
    Agressologie; 1982; 23(3):115-7. PubMed ID: 7180979
    [No Abstract]   [Full Text] [Related]  

  • 11. Aging of rat erythrocytes: differences in genetically high and low 2,3-DPG rat lines.
    Noble NA; Kuwashima LH; Mairbaurl H
    Prog Clin Biol Res; 1984; 165():241-61. PubMed ID: 6504911
    [No Abstract]   [Full Text] [Related]  

  • 12. [Level of 2,3-diphosphoglycerate and adenosine triphosphate in erythrocytes and acid-base status in adult and newborn rats in acute hypoxia].
    Alatyrtsev VV; Aleksandrov AE; Lekmanov AU; Bakanov MI
    Biull Eksp Biol Med; 1995 Jun; 119(6):631-3. PubMed ID: 8589391
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oxygenation curves in enzymopathic hemolytic anemias].
    Rotrekl B; Prokopová M
    Acta Univ Palacki Olomuc Fac Med; 1984; 106():123-31. PubMed ID: 6242617
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanism of changes in the rate of glycolysis and levels of ATP and 2,3-diphosphoglycerate in human erythrocytes during aging].
    Bogatskaia LN; Pisaruk AV
    Ukr Biokhim Zh (1978); 1987; 59(5):81-3. PubMed ID: 3686699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic anemia and somatic cell dysfunction in severe hypophosphatemia.
    Klock JC; Williams HE; Mentzer WC
    Arch Intern Med; 1974 Aug; 134(2):360-4. PubMed ID: 4843204
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the erythrocyte, 2,3-DPG and ATP content in leukemic diseases].
    Iordanova E; Arnaudov G
    Vutr Boles; 1981; 20(2):119-23. PubMed ID: 6942591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of erythrocyte metabolism using 31P NMR-spectroscopy].
    Cernay P; Gajdos M; Zalibera L; Golier I
    Bratisl Lek Listy; 1986 Sep; 86(3):273-80. PubMed ID: 3756559
    [No Abstract]   [Full Text] [Related]  

  • 18. [Determination of 2,3-diphosphoglyceric acid by a nonenzymatic method and levels of 2,3-diphosphoglycerate and ATP in the erythrocytes of patients with chronic lympholeukemia].
    Luganova IS; Blinov MN
    Lab Delo; 1975; (11):652-4. PubMed ID: 54485
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of nuclear magnetic resonance in the study of hemolytic anemia. Preliminary report].
    Fábryová V; Hammerová T; Zalibera L; Goljer I; Sakalová A
    Vnitr Lek; 1991 Apr; 37(4):352-8. PubMed ID: 2053305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological manipulation of 2,3 DPG levels and oxygen affinity.
    Farber MO
    Prog Clin Biol Res; 1984; 165():263-77. PubMed ID: 6438646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.